Evidence map›Paper›PMID 9060672›Full record

ArticleJournal of virology1997

Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo.

S Ponnazhagan, M C Yoder, A Srivastava

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 75 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Recombinant AAV2 transduction of primitive human hematopoietic stem cells capable of serial engraftment in immune-deficient mice.Proceedings of the National Academy of Sciences of the United States of America · 2005
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

S PonnazhaganDepartment of Medicine, Indiana University School of Medicine, Indianapolis 46202-5120, USA.
M C Yoder
A Srivastava
Indiana University – Purdue University Indianapolis · US

Funding

VectorP01HL053586 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI CLAPP, DAVID W · 1995 to 2009
$16.0M
PILOT AND FEASIBILITY STUDIESP30DK049218 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SROUR, EDWARD F · 1999 to 2004
$4.6M
GENETIC MODIFICATION/ALTERNATIVE SOURCES OF STEM CELLP50DK049218 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI LIECHTY, EDWARD A · 1994 to 1998
–
PARVOVIRUS-MEDIATED GENE TRANSFER IN STEM CELLSR01HL048342 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SRIVASTAVA, ARUN · 1992 to 1996
–
NHLBI NIH HHS HL-48342NHLBI NIH HHS HL-53586NIDDK NIH HHS DK-49218
6 · The paper itself

Abstract

Adeno-associated virus type 2 (AAV), a nonpathogenic human parvovirus, is gaining attention as a vector for potential use in human gene therapy. We and others have described AAV-mediated beta-globin gene transfer and expression in established human and murine erythroleukemia cell lines in vitro. However, successful AAV-mediated globin gene transduction of hematopoietic stem cells and long-term expression in vivo in progeny cells have not been documented. We report here that infection of murine hematopoietic bone marrow cells ex vivo with a recombinant AAV vector containing the genomic copy of a normal human globin gene followed by transplantation of these cells into lethally irradiated congenic mice resulted in efficient gene transfer into hematopoietic cells with long-term repopulating ability as detected by the presence of the human globin gene sequences in bone marrow and spleen in primary recipient mice for at least 6 months. Long-term expression of the human globin gene was also detected in bone marrow, but not in spleen, in primary recipient mice. Furthermore, in secondary-transplant experiments, we were also able to document the presence as well as expression of the transduced human globin gene in mouse bone marrow for up to 3 months. These results provide further support for potential use of the AAV-based vector system in gene therapy of human hemoglobinopathies in general and sickle-cell anemia and beta-thalassemia in particular.

Indexed as

Genetic VectorsGene Transfer TechniquesAnimalsBone Marrow CellsCell DivisionCells, CulturedCloning, MolecularDependovirusGene ExpressionGlobinsHematopoietic Stem CellsHematopoietic Stem Cell TransplantationHumansMiceMice, Inbred C57BLTime FactorsGlobins

Identifiers

PMID9060672
PMCPMC191441
OpenAlexW2143909552

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.